Replacement Arthroplasty of the First Metatarsophalangeal Joint Using a Ceramic-Coated Endoprosthesis for the Treatment of Hallux Rigidus

We prospectively assessed 40 patients who underwent total first metatarsophalangeal joint replacement arthroplasty using a ceramic implant for the treatment of hallux rigidus. A total of 42 toes in 40 patients were included in the assessment. Preoperatively, the mean American Orthopaedic Foot and Ankle Society (AOFAS) hallux first metatarsal score was 36.00 ± 10.79 points, and first metatarsophalangeal joint range of motion was 4.9° ± 5.52°. The mean preoperative AOFAS score increased from 36.00 ± 10.79 to 82.20 ± 9.54 at 3 months (P < .001), to 87.00 ± 10.62 at 12 months, and to 84.20 ± 10.69 at 24 months. There was no statistically significant change in scores from 3 months onward. Range of motion increased to 70.80° ± 15.97° in the operating room and reduced to 45.60° ± 12.28° at 3 months postoperative, decreasing to 40.00° ± 12.72° at 12 months and 33.30° ± 17.19° at 24 months postop. We advocate total toe arthroplasty with this all-ceramic press-fit implant as an effective procedure for the treatment of moderate to severe hallux rigidus. This ceramic, total first metatarsophalangeal joint endoprosthesis yields good improvement in foot-related quality-of-life scores, reasonable range of motion, and a low early revision rate. Level of Clinical Evidence: 2